Close Menu
    Facebook X (Twitter) Instagram
    ScoopSquare24
    • Home
    • News
    • AI
    • Crypto
    • Finance
    • Stocks
    Facebook X (Twitter) Instagram
    ScoopSquare24
    Home»News»Stocks»DocuSign (DOCU) Stock Hit With Analyst Downgrades After Q4 Earnings Report
    Stocks

    DocuSign (DOCU) Stock Hit With Analyst Downgrades After Q4 Earnings Report

    Oli DaleBy Oli DaleMarch 18, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Key Highlights

    • Citizens slashed its DocuSign price target from $124 down to $86, expressing worries about revenue expansion, though maintained its Market Outperform stance
    • Wells Fargo reduced its price target from $75 to $60, keeping an Equal Weight position
    • DOCU shares have declined 44% in the last half-year, trading near $47.54
    • Fourth quarter FY2026 earnings per share reached $1.01, surpassing analyst estimates of $0.95; quarterly revenue of $837M exceeded the $827.9M projection
    • IAM product line generated $350M (representing 11% of overall revenue) in Q4, with projections targeting $600M (18% of total) by FY2027’s close

    The past six months have been challenging for DocuSign, prompting Wall Street analysts to recalibrate their outlook. This week saw two financial institutions reduce their price projections for the e-signature company — one making a particularly aggressive cut.


    DOCU Stock Card
    DocuSign, Inc., DOCU

    Citizens made a substantial adjustment, lowering its price objective from $124 down to $86, representing a 31% decrease. Despite this significant revision, the firm continues to maintain its Market Outperform recommendation. According to Citizens, concerns about future revenue growth momentum prompted the adjustment.

    Shares are currently changing hands around $47.54 — significantly beneath even these newly reduced price objectives — representing a 44% decline over the preceding six-month period. This represents a substantial pullback for an organization still maintaining gross profit margins of 79.5% while holding more cash reserves than outstanding debt obligations.

    Wells Fargo adopted a less dramatic stance, adjusting its price target downward from $75 to $60 while maintaining its Equal Weight recommendation. The firm characterized Q4 performance as generally meeting expectations, albeit “a touch below” the stronger beats witnessed in recent quarters.

    Wells Fargo emphasized that elevated research and development spending will likely constrain margin improvement in upcoming periods. Fresh company disclosures also necessitate analysts reconfiguring their forward-looking financial models.

    Fourth Quarter Performance Exceeds Forecasts

    Notwithstanding the pessimistic price target adjustments, DocuSign’s fourth quarter FY2026 performance actually demonstrated solid fundamentals. Earnings per share registered at $1.01, outpacing the $0.95 analyst consensus. Quarterly revenue totaled $837 million, marginally surpassing the $827.9 million forecast.

    The earnings beat failed to alleviate apprehensions regarding future expansion velocity, which remains the primary catalyst behind these target reductions.

    IAM Platform and Artificial Intelligence Developments

    Optimistic investors are focusing attention on the company’s IAM platform, which generated $350 million during Q4, accounting for 11% of aggregate revenue. Management has projected this figure will reach $600 million, or 18% of consolidated revenue, by FY2027’s conclusion.

    The organization is transitioning to consumption-driven subscription pricing beginning in the first quarter.

    Regarding artificial intelligence initiatives, the company’s Iris engine now processes over 200 million privately consented agreements through Navigator, up from 150 million recorded in December. Management reports achieving AI processing cost reductions of up to 50 times compared to executing direct prompts through large language models.

    DocuSign operates within a $50 billion total addressable market opportunity, divided equally between electronic signature solutions and contract lifecycle management services, while serving 1.8 million customers throughout its ecosystem.

    Wells Fargo observed that updated ARR guidance indicates approximately 50 basis points of acceleration entering FY2027.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Oli Dale
    • Website

    Related Posts

    Circle Internet (CRCL) Hit with Class Action Lawsuit Over $280M Drift Protocol Breach

    April 17, 2026

    JPMorgan Analysts Say CLARITY Act Could Pass Before Midterm Elections

    April 17, 2026

    Tom Lee Predicts Further Gains After April 2026 Market Records

    April 17, 2026
    Leave A Reply Cancel Reply

    Breaking News
    Blockonomi

    Crypto News Just Turned Bullish: Coinbase CEO Brian Armstrong Calls a $60,000 Bitcoin Bottom While DOGE Holders Move to Pepeto

    Blockonomi
    Jun 16, 2026 9:27 PM
    Parameter

    CervoMed (CRVO) Stock Soars 32% on $3 Million Director Purchase

    Parameter
    Jun 16, 2026 8:27 PM
    Blockonomi

    CervoMed (CRVO) Surges 32% as Director Purchases $3 Million in Shares

    Blockonomi
    Jun 16, 2026 8:24 PM
    Moneycheck

    CervoMed (CRVO) Surges 32% Following Director’s $3 Million Stock Purchase

    Moneycheck
    Jun 16, 2026 8:24 PM
    Parameter

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Assessment of mRNA Flu Vaccine

    Parameter
    Jun 16, 2026 8:20 PM
    Blockonomi

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Review of mRNA Flu Vaccine

    Blockonomi
    Jun 16, 2026 8:17 PM
    Moneycheck

    Moderna (MRNA) Stock Surges 9% After FDA Gives Positive Signal on mRNA Flu Vaccine

    Moneycheck
    Jun 16, 2026 8:17 PM
    Coincentral

    CervoMed (CRVO) Stock Jumps 32% After Director Buys $3M – Time to Buy?

    Coincentral
    Jun 16, 2026 8:14 PM
    Parameter

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade from Underperform

    Parameter
    Jun 16, 2026 8:13 PM
    Blockonomi

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Blockonomi
    Jun 16, 2026 8:10 PM
    Moneycheck

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Moneycheck
    Jun 16, 2026 8:10 PM
    Coincentral

    Moderna (MRNA) Stock Jumps 9% as FDA Clears Key Hurdle for mRNA Flu Shot

    Coincentral
    Jun 16, 2026 8:06 PM
    Coincentral

    Palantir (PLTR) Stock Falls 2% Even After Getting a Wall Street Upgrade

    Coincentral
    Jun 16, 2026 8:01 PM
    Blockonomi

    Anchorage Digital Unlocks New SWEEP Infrastructure for Institutions

    Blockonomi
    Jun 16, 2026 7:16 PM
    Parameter

    Alphabet (GOOG) Stock: Rises as Google Expands Android 17 Parental Controls

    Parameter
    Jun 16, 2026 7:13 PM
    Facebook X (Twitter) Instagram Pinterest
    ScoopSquare24

    Copyright © 2013 - 2026 Kooc Media Ltd. All rights reserved. Registered Company No.05695741
    Our Sites: FlowPresets / GardenBeast / GolfMonster / Blockonomi / Money Check / CoinCentral / Parameter / Circlo / Computing.net

    Type above and press Enter to search. Press Esc to cancel.